220 related articles for article (PubMed ID: 23496027)
21. Achieving goal lipid levels with ezetimibe plus statin add-on or switch therapy compared with doubling the statin dose. A pooled analysis.
Ambegaonkar BM; Tipping D; Polis AB; Tomassini JE; Tershakovec AM
Atherosclerosis; 2014 Dec; 237(2):829-37. PubMed ID: 25463129
[TBL] [Abstract][Full Text] [Related]
22. Brain cholesterol synthesis in mice is affected by high dose of simvastatin but not of pravastatin.
Thelen KM; Rentsch KM; Gutteck U; Heverin M; Olin M; Andersson U; von Eckardstein A; Björkhem I; Lütjohann D
J Pharmacol Exp Ther; 2006 Mar; 316(3):1146-52. PubMed ID: 16282522
[TBL] [Abstract][Full Text] [Related]
23. TNF-α modulates statin effects on secretion and expression of MCP-1, PAI-1 and adiponectin in 3T3-L1 differentiated adipocytes.
Lobo SM; Quinto BM; Oyama L; Nakamichi R; Ribeiro AB; Zanella MT; Dalboni MA; Batista MC
Cytokine; 2012 Oct; 60(1):150-6. PubMed ID: 22658637
[TBL] [Abstract][Full Text] [Related]
24. Simvastatin-ezetimibe combination therapy is associated with a lower rate of major adverse cardiac events in type 2 diabetics than high potency statins alone: A population-based dynamic cohort study.
Chang SH; Wu LS; Lee CH; Kuo CT; Liu JR; Wen MS; Chen WJ; See LC; Yeh YH
Int J Cardiol; 2015; 190():20-5. PubMed ID: 25912112
[TBL] [Abstract][Full Text] [Related]
25. The effects of high dose pravastatin and low dose pravastatin and ezetimibe combination therapy on lipid, glucose metabolism and inflammation.
Dagli N; Yavuzkir M; Karaca I
Inflammation; 2007 Dec; 30(6):230-5. PubMed ID: 17687635
[TBL] [Abstract][Full Text] [Related]
26. Safety and efficacy of combined ezetimibe/simvastatin treatment and simvastatin monotherapy in patients with non-alcoholic fatty liver disease.
Abel T; Fehér J; Dinya E; Eldin MG; Kovács A
Med Sci Monit; 2009 Dec; 15(12):MS6-11. PubMed ID: 19946244
[TBL] [Abstract][Full Text] [Related]
27. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
[TBL] [Abstract][Full Text] [Related]
28. Ezetimibe/simvastatin: a guide to its clinical use in hypercholesterolemia.
Lyseng-Williamson KA
Am J Cardiovasc Drugs; 2012 Feb; 12(1):49-56. PubMed ID: 22208355
[TBL] [Abstract][Full Text] [Related]
29. Simvastatin versus ezetimibe: pleiotropic and lipid-lowering effects on endothelial function in humans.
Landmesser U; Bahlmann F; Mueller M; Spiekermann S; Kirchhoff N; Schulz S; Manes C; Fischer D; de Groot K; Fliser D; Fauler G; März W; Drexler H
Circulation; 2005 May; 111(18):2356-63. PubMed ID: 15867181
[TBL] [Abstract][Full Text] [Related]
30. Rosiglitazone increases cell surface GLUT4 levels in 3T3-L1 adipocytes through an enhancement of endosomal recycling.
Martinez L; Berenguer M; Bruce MC; Le Marchand-Brustel Y; Govers R
Biochem Pharmacol; 2010 May; 79(9):1300-9. PubMed ID: 20026082
[TBL] [Abstract][Full Text] [Related]
31. Coadministration of dalcetrapib with pravastatin, rosuvastatin, or simvastatin: no clinically relevant drug-drug interactions.
Derks M; Abt M; Phelan M; Turnbull L; Meneses-Lorente G; Bech N; White AM; Parr G
J Clin Pharmacol; 2010 Oct; 50(10):1188-201. PubMed ID: 20489031
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of ezetimibe/simvastatin 10/40 mg compared to doubling the dose of low-, medium- and high-potency statin monotherapy in patients with a recent coronary event.
Brudi P; Reckless JP; Henry DP; Pomykaj T; Lim ST; Massaad R; Vandormael K; Johnson-Levonas AO
Cardiology; 2009; 113(2):89-97. PubMed ID: 19018143
[TBL] [Abstract][Full Text] [Related]
33. Dimethyl sulfoxide enhances GLUT4 translocation through a reduction in GLUT4 endocytosis in insulin-stimulated 3T3-L1 adipocytes.
Berenguer M; Zhang J; Bruce MC; Martinez L; Gonzalez T; Gurtovenko AA; Xu T; Le Marchand-Brustel Y; Govers R
Biochimie; 2011 Apr; 93(4):697-709. PubMed ID: 21195125
[TBL] [Abstract][Full Text] [Related]
34. Redox markers and inflammation are differentially affected by atorvastatin, pravastatin or simvastatin administered before endotoxin-induced acute lung injury.
Melo AC; Valença SS; Gitirana LB; Santos JC; Ribeiro ML; Machado MN; Magalhães CB; Zin WA; Porto LC
Int Immunopharmacol; 2013 Sep; 17(1):57-64. PubMed ID: 23747588
[TBL] [Abstract][Full Text] [Related]
35. Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors.
Jacobson TA
Am J Cardiol; 2004 Nov; 94(9):1140-6. PubMed ID: 15518608
[TBL] [Abstract][Full Text] [Related]
36. Simvastatin but not ezetimibe reduces sympathetic activity despite similar reductions in cholesterol levels.
Lewandowski J; Siński M; Puchalska L; Symonides B; Gaciong Z
J Am Soc Hypertens; 2014 Oct; 8(10):715-23. PubMed ID: 25418493
[TBL] [Abstract][Full Text] [Related]
37. Incremental cholesterol reduction with ezetimibe/simvastatin, atorvastatin and rosuvastatin in UK General Practice (IN-PRACTICE): randomised controlled trial of achievement of Joint British Societies (JBS-2) cholesterol targets.
McCormack T; Harvey P; Gaunt R; Allgar V; Chipperfield R; Robinson P;
Int J Clin Pract; 2010 Jul; 64(8):1052-61. PubMed ID: 20487050
[TBL] [Abstract][Full Text] [Related]
38. Lipid-altering efficacy and safety profile of combination therapy with ezetimibe/statin vs. statin monotherapy in patients with and without diabetes: an analysis of pooled data from 27 clinical trials.
Leiter LA; Betteridge DJ; Farnier M; Guyton JR; Lin J; Shah A; Johnson-Levonas AO; Brudi P
Diabetes Obes Metab; 2011 Jul; 13(7):615-28. PubMed ID: 21332628
[TBL] [Abstract][Full Text] [Related]
39. Reduced mitochondrial coenzyme Q10 levels in HepG2 cells treated with high-dose simvastatin: a possible role in statin-induced hepatotoxicity?
Tavintharan S; Ong CN; Jeyaseelan K; Sivakumar M; Lim SC; Sum CF
Toxicol Appl Pharmacol; 2007 Sep; 223(2):173-9. PubMed ID: 17610923
[TBL] [Abstract][Full Text] [Related]
40. Differential effects of pravastatin and simvastatin on the growth of tumor cells from different organ sites.
Menter DG; Ramsauer VP; Harirforoosh S; Chakraborty K; Yang P; Hsi L; Newman RA; Krishnan K
PLoS One; 2011; 6(12):e28813. PubMed ID: 22216116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
